| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/06/2010 | CN100577798C Formula constituted by cytokine and compound, its action of promoting nerve regeneration and action of researching and diagnosing nervous system disease |
| 01/06/2010 | CN100577198C Medicine for curing cardio-cerebrovascular disease |
| 01/06/2010 | CN100577196C Medicine for treating gastric ulcer and duodenal ulcer |
| 01/06/2010 | CN100577194C Powder medicine for treating hyperosteogeny |
| 01/06/2010 | CN100577192C Medicine preparation for stagnate-removing and pulse-restoring |
| 01/06/2010 | CN100577191C Ointment for treating bone diseases and its preparing method |
| 01/06/2010 | CN100577190C Medicine for treating cancer |
| 01/06/2010 | CN100577170C Application of pyrazolopyrimidine Src family tyrosine kinase inhibitor in preparing medicament for curing myocardial infarction |
| 01/06/2010 | CN100577035C Lactic-acid fermented materials able to restrain rotavirus infection and preparation method thereof |
| 01/05/2010 | US7642342 Generate immune response by activation of a T cell or a B cell to claimed peptide, nucleotide expressed in a viral vector; vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, Sindbis virus; diagnostic and therapeutic applications |
| 01/05/2010 | US7642092 for isolating chondrocytes from mandibular condyle tissue and being depleted of fibroblast-like cells and/or myocytes; enzyme inhibitors |
| 01/05/2010 | US7642081 Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same |
| 01/05/2010 | US7641924 Proteins, lipids and carbohydrates including glucose and fructose heterodisaccharides; slow hydrolysis |
| 01/05/2010 | US7641918 Plasma cryoprecipitate substantially free of plasminogen |
| 01/05/2010 | US7641899 Methods for inhibiting IL-TIF-induced proliferation of hematopoietic cells using the cytokine receptor Zcytor16 |
| 01/05/2010 | US7641898 cells are dispersed using an air-jet sprayer after being suspended in a soluble media either directly onto the area or onto a tissue scaffold to form three dimensional epithelial tissue |
| 01/05/2010 | US7641896 Adjuvant viral particle |
| 01/05/2010 | CA2473503C Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 01/05/2010 | CA2369884C Transiently immortalized cells for use in gene therapy |
| 01/05/2010 | CA2349475C Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 01/05/2010 | CA2300480C Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| 01/05/2010 | CA2164835C Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 12/31/2009 | US20090328242 Replication of Undifferentiated Cells in a Weightless Environment, Uses Thereof and a Facility for Such Replication and the Acceleration of the Evolution of Plants and Animals |
| 12/31/2009 | US20090326607 Electrical Stimulation Method for Treatment of Peripheral Neuropathy |
| 12/31/2009 | US20090326423 Stimulation of cartilage formation using reduced pressure treatment |
| 12/31/2009 | US20090326206 Single-chain Multiple Antigen-binding Molecule, Its Preparation and Use |
| 12/31/2009 | US20090325886 Wt1 modified peptide |
| 12/31/2009 | US20090325880 Tnf receptor-like molecules and uses thereof |
| 12/31/2009 | US20090325289 Process for the multiplication of stem cells |
| 12/31/2009 | US20090325180 Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells |
| 12/31/2009 | US20090324734 Throat care composition |
| 12/31/2009 | US20090324733 Composition of Whey Growth Factor Extract for Reducing Muscle Inflammation |
| 12/31/2009 | US20090324732 Method for the production of milk or milk products with a high proportion of melatonin |
| 12/31/2009 | US20090324702 Novel viral vector |
| 12/31/2009 | US20090324681 Vascularization Enhanced Graft Constructs |
| 12/31/2009 | US20090324674 Genetically modified heart valve xenografts |
| 12/31/2009 | US20090324651 Methods for Stimulating an Immune Response Using Bacterial Antigen Delivery System |
| 12/31/2009 | US20090324643 Compositions and methods for treating and preventing infection |
| 12/31/2009 | US20090324632 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 12/31/2009 | US20090324609 Method of treating autoimmune disease with mesenchymal stem cells |
| 12/31/2009 | US20090324607 Therapeutic Transplantation Using Developing, Human or Porcine, Renal or Hepatic, Grafts |
| 12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 12/31/2009 | US20090324584 Nucleic Acid of Formula (I): GIXmGn, or (II): CIXmCn, in Particular as an Immune-Stimulating Agent/Adjuvant |
| 12/31/2009 | US20090324567 Leukocyte Cell Banks |
| 12/31/2009 | US20090324565 A Colicinogenic Strain of E. Coli |
| 12/31/2009 | US20090324563 Moisturizer |
| 12/31/2009 | US20090324562 Defensin Proteins |
| 12/31/2009 | US20090324561 Cells exhibiting neuronal progenitor cell characteristics and methods of making them |
| 12/31/2009 | US20090324560 Method for preparation of cartilage cell |
| 12/31/2009 | US20090324557 Method to induce and expand therapeutic alloantigen-specific human regulatory t cells in large-scale |
| 12/31/2009 | US20090324556 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof |
| 12/31/2009 | US20090324555 Neural Stem Cells |
| 12/31/2009 | US20090324553 Chimeric Viral Envelopes |
| 12/31/2009 | US20090324552 Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders |
| 12/31/2009 | US20090324549 Proteins and/or peptides for the prevention and/or treatment of neurodegenerative diseases |
| 12/31/2009 | US20090324548 Clonal strain of attenuated vaccinia virus that can be used to prevent or treat small pox |
| 12/31/2009 | US20090324547 Probiotic Oral Health Promoting Product |
| 12/31/2009 | DE202009012891U1 Mittel und Einrichtung zur Wärmebehandlung mit Erd- und Bienenwachsgemisch Means and equipment for the heat treatment of earth- and beeswax mixture |
| 12/31/2009 | DE202008011216U1 Dermatologische Salbe Dermatological ointment |
| 12/31/2009 | DE112007000030B4 Verfahren zur Isolierung einer Haarfollikelstammzelle und Zusammensetzung für die Haarreproduktion A method for isolating a Haarfollikelstammzelle and Hair composition Reproduction |
| 12/30/2009 | WO2009158480A2 Stimulation of cartilage formation using reduced pressure treatment |
| 12/30/2009 | WO2009158384A1 Methods and kits for the treatment inhibition, and maintenance of gastrointestinal disorders |
| 12/30/2009 | WO2009157802A1 Strain of a реniсilliuм vеrruсоsuм fungus for producing agent exhibiting immunomodulating properties and an immunomodulator agent based thereon |
| 12/30/2009 | WO2009157767A1 Nutritional composition for improving the mammalian immune system |
| 12/30/2009 | WO2009157759A1 Nutritional composition for improving the mammalian immune system |
| 12/30/2009 | WO2009157562A1 Method for establishment of adult pancreatic stem cell, and method for differentiation of adult pancreatic stem cell |
| 12/30/2009 | WO2009157559A1 Pancreatic cell regeneration/transplantation kit for pancreatic diseases or diabetes |
| 12/30/2009 | WO2009157073A1 Nano-level lactic acid bacterium |
| 12/30/2009 | WO2009156307A1 Probiotics, secretory iga and infection |
| 12/30/2009 | WO2009156301A1 Probiotics, secretory iga and inflammation |
| 12/30/2009 | WO2009156151A1 Mesoangioblast-like cell as well as methods and uses relating thereto |
| 12/30/2009 | WO2009155711A1 Analysis of lactobacillus acidophilus la-5 signal interference molecules |
| 12/30/2009 | WO2009155689A1 Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections |
| 12/30/2009 | WO2009155656A1 Repair and/or reconstitution of invertebral discs |
| 12/30/2009 | WO2009155637A1 Protocols for treating and preventing obesity and complications arising therefrom |
| 12/30/2009 | WO2009117553A3 Enhancing vessel lesion homing and repair potential of stem cells |
| 12/30/2009 | WO2009114547A3 Enhanced dendritic cells for cancer immunotherapy |
| 12/30/2009 | WO2009001204A3 Mitogen activated protein kinase modulator |
| 12/30/2009 | WO2008157624A3 Lactose reduced milk |
| 12/30/2009 | EP2138580A1 Vector for gene therapy |
| 12/30/2009 | EP2138572A1 Mesoangioblast-like cell as well as methods and uses relating thereto |
| 12/30/2009 | EP2138187A1 Probiotics, secretory IgA and infection |
| 12/30/2009 | EP2138186A1 Probiotics, secretory IgA and inflammation |
| 12/30/2009 | EP2138181A1 Method of preparing decellularized soft tissue, graft and culture material |
| 12/30/2009 | EP2138179A1 Use of cytidine derivatives for the treatment of leukaemia |
| 12/30/2009 | EP2138159A1 Whitening agent |
| 12/30/2009 | EP2137300A1 Pluripotent autologous stem cells from oral mucosa and methods of use |
| 12/30/2009 | EP2136825A2 Use of lactobacillus plantarum for increasing bacterial diversity |
| 12/30/2009 | EP2136824A1 Use of selected lactic acid bacteria for reducing atherosclerosis |
| 12/30/2009 | EP2136823A1 Telencephalic glial-restricted cell populations and related compositions and methods |
| 12/30/2009 | EP2136631A1 Methods for treating neoplasia with combination of chemotherapeutic agents and radiation |
| 12/30/2009 | EP2004625B1 C-met protein kinase inhibitors for the treatment of proliferative disorders |
| 12/30/2009 | EP1530642B1 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions |
| 12/30/2009 | EP1523541B1 A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
| 12/30/2009 | EP1509597B1 Method for isolating hair follicle mesenchymal stem cells |
| 12/30/2009 | EP0863754B2 Hydrolysis-optimized lipid emulsions and use thereof |
| 12/30/2009 | CN201370888Y Multifunctional medicated pad |
| 12/30/2009 | CN101616680A Agent for reducing visceral fat |
| 12/30/2009 | CN101616679A Composition for the treatment of skin conditions |
| 12/30/2009 | CN101612169A Inactivated lactobacillus micro-ecological preparation and preparation method thereof |